First Eagle Investment Management LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 50.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,266,712 shares of the company's stock after selling 3,324,418 shares during the period. HCA Healthcare comprises approximately 2.1% of First Eagle Investment Management LLC's investment portfolio, making the stock its 13th biggest holding. First Eagle Investment Management LLC owned approximately 1.56% of HCA Healthcare worth $1,394,037,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. BlackRock Inc. acquired a new position in shares of HCA Healthcare in the second quarter valued at $5,069,974,000. Legal & General Group Plc bought a new position in HCA Healthcare in the 2nd quarter valued at about $410,992,000. Jupiter Topco LLC acquired a new stake in HCA Healthcare during the second quarter worth approximately $371,138,000. Wellington Management Group LLP boosted its holdings in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock worth $1,835,397,000 after acquiring an additional 799,761 shares during the period. Finally, Bank of America Corp DE acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $238,457,000. 62.73% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, EVP Michael Schlosser sold 1,200 shares of the company's stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the transaction, the executive vice president directly owned 1,443 shares in the company, valued at $713,779.95. This represents a 45.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Jon Foster sold 21,713 shares of the firm's stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the sale, the chief operating officer owned 10,000 shares in the company, valued at $4,949,500. This represents a 68.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 36,413 shares of company stock worth $18,251,464 in the last three months. 1.50% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on HCA shares. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, October 31st. UBS Group decreased their price objective on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Royal Bank Of Canada lifted their target price on HCA Healthcare from $496.00 to $521.00 and gave the stock an "outperform" rating in a report on Friday, October 30th. Bank of America boosted their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company a "neutral" rating in a research report on Wednesday, October 28th. Finally, Truist Financial reaffirmed a "buy" rating and set a $510.00 price target (up from $495.00) on shares of HCA Healthcare in a research report on Tuesday, November 3rd. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $480.13.
Read Our Latest Stock Report on HCA
HCA Healthcare Stock Performance
HCA opened at $500.82 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The firm has a market cap of $104.62 billion, a P/E ratio of 17.08, a price-to-earnings-growth ratio of 1.71 and a beta of 1.11. The business's fifty day moving average is $456.91 and its 200-day moving average is $446.11.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion for the quarter, compared to analyst estimates of $19.33 billion. During the same quarter last year, the company posted $6.96 EPS. The company's revenue for the quarter was up 3.6% compared to the same quarter last year. On average, research analysts predict that HCA Healthcare, Inc. will post 30.14 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare's payout ratio is 10.34%.
About HCA Healthcare
(
Free Report)
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Stories
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.